TMCI Investors Have Final Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit with the Schall Law Firm

  • LOS ANGELES , June 9, 2025 /PRNewswire/ --  The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Treace Medical Concepts, Inc. ("Treace" or "the Company") (NASDAQ: TMCI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 8, 2023 and May 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 10, 2025.